Higher specialty training in urology in Ireland is a six-year RCSI programme (ST3-ST8) during which trainees rotate through at least four of the eight major academic urology units in the country. The specialty holds an annual national meeting at which trainees present original research, and the RCSI Fellowship (FRCS) exam is required for the Certificate of Completion of Surgical Training and Irish Medical Council registration eligibility.
Work and interests
Urology combines diagnosis and treatment of urinary tract and male reproductive disorders with operative and procedural work. Rotations across academic units expose trainees to core procedures and subspecialty practice.
Entry and selection for 2027
Entry is through direct progression from CST2 or ESR after completed CST or recognised equivalent training and the MRCS. ESR requires at least 12 months full-time equivalent experience in a standalone post in the chosen specialty, with logbooks, trainer reports, qualification evidence and any required operative-skills/human-factors assessments. Medical Council and English-language eligibility also apply.
For 2027, direct Pathway scoring is CST500 (CAPA/logbook/OSCEs 425 and weighted MRCS PartB75), academic 40 and interview 460, totalling 1000. The five interview weights are 100,40,100,120 and 100 for quality/safety, academic development, current surgical issues, decision making, and professionalism/probity respectively.
The 2027 cardiothoracic/urology guide has inconsistent ESR totals: its summary retains CST500, post-CST clinical 65, academic 75 and interview 360, while its interview table gives 400. Cardiothoracic also explicitly excludes academic scoring. Confirm the operative ESR calculation with RCSI before estimating an overall score. The ESR interview table has five 80-mark stations.
Both routes require at least 60% pre-interview and 60% overall interview, plus a mandatory 60% pass in decision-making station 4. Passing the aggregate cannot compensate for failing that station. For ESR, reaching 60% does not guarantee an interview; a 3:1 applicant-to-post shortlist may be used.
Applying
July 2027: direct Pathway applications 15 October–13 November 2026. ESR applications open 14 October 2026 at 12 noon and close 13 November 2026 at 12 noon; submit the required hard copy. Eligible academic and final-six-month clinical evidence updates are accepted to 8 January 2027. The ESR form lists 24 March 2027 for interview, subject to confirmation; confirm your individual invitation because the intake guide gives a broader March timetable.